Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral).
Saseedharan S, Dubey D, Singh RK, Zirpe K, Choudhuri AH, Mukherjee DN, Gupta N, Sahasrabudhe S, Soni S, Kulkarni S, Walse P, Vora AC, Thomas J, Tayade A, Bhadarke G, Kishore K, Paliwal Y, Patil P, Reddy PK, Nagvekar V, Veeraraghavan B.
Saseedharan S, et al. Among authors: soni s.
Indian J Med Microbiol. 2024 Jan-Feb;47:100528. doi: 10.1016/j.ijmmb.2024.100528. Epub 2024 Jan 21.
Indian J Med Microbiol. 2024.
PMID: 38228227